Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors.
Open Access
- 1 December 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 137 (11) , 3577-3583
- https://doi.org/10.4049/jimmunol.137.11.3577
Abstract
Receptors for C3 degradation fragments (CR1, CR2, and CR3) are present on many human cells including phagocytes and lymphoid cells and may be critical in the attachment of invading microorganisms. In these studies Candida were found to mimic the human CR by binding erythrocytes coated with specific human C3 fragments. Yeast forms of Candida species were adhered to glass slides and were allowed to germinate. Sheep erythrocytes (E) were coated with IgM (EA) and human complement components to prepare EA, EAC14, EAC3b, EAC3bi, and EAC3d. These test cells were then examined for adherence to the organism. Antibodies to human CR1, CR2, and CR3 were used to evaluate their potential for blocking adherence of the test erythrocytes to Candida. Fluorescein-labeled antibodies to human complement receptors were also used to characterize the binding sites. EAC3bi and EAC3d, but not E, EA, or EAC14, bound extensively to the germ tubes and pseudohyphae of Candida albicans and C. stellatoidea. EAC3b bound infrequently. Other Candida species, generally considered less pathogenic, bound significantly fewer specific test erythrocytes than C. albicans. Monoclonal antibodies to human CR1 and CR3 (3D9, 1B4, C511, 2B6, anti-B2, Mo1, and anti-Mac-1), in general, did not block adherence of test erythrocytes. Blocking of adherence of EAC3bi and EAC3d test erythrocytes coated with small quantities of C3 fragments occurred with high concentrations of monoclonal (anti-CR2) HB-5 and polyclonal (anti-CR2) anti-GP 140. Immunofluorescence studies demonstrated binding of Mo-1 to the germinated forms of the organism, whereas binding of the other antibodies was not seen. These studies suggest a surface constituent on the organism similar to CR on human cells. Additional studies are necessary to further define the molecular nature of the binding site. The ability of organisms to mimic human CR may be more generalized than previously known and may serve as a mechanism for modification of the inflammatory and immune response.This publication has 15 references indexed in Scilit:
- Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.The Journal of Experimental Medicine, 1983
- Complement receptor expression by neoplastic and normal human cells.The Journal of Immunology, 1983
- Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens.The Journal of Immunology, 1983
- C3d receptors are expressed on human monocytes after in vitro cultivation.Proceedings of the National Academy of Sciences, 1983
- Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.The Journal of Experimental Medicine, 1982
- Fc and C3 Receptors Induced by Herpes Simplex Virus on Cultured Human Endothelial CellsJournal of Clinical Investigation, 1982
- Large scale isolation of functionally active components of the human complement system.Journal of Biological Chemistry, 1981
- STUDIES OF THE MOLECULAR MECHANISMS OF C3B INACTIVATION AND A SIMPLIFIED ASSAY OF BETA-1H AND THE C3B INACTIVATOR (C3BINA)1979
- Alternative Pathway of Complement Activation by Candida AlbicansAustralian and New Zealand Journal of Medicine, 1978
- Role of Complement in Host Defense against Experimental Disseminated CandidiasisThe Journal of Infectious Diseases, 1978